Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Accu-Chek

This article was originally published in The Gray Sheet

Executive Summary

Blood glucose test strip maker is revising Advantage II strip instructions and training materials to draw attention to the fact that maltose is listed as an interfering substance. An MHRA alert April 16 in the UK cautions there is a risk of overestimation of blood glucose results when the strips, used with Roche's Advantage and Inform meters, are used on patients taking treatments containing maltose. MHRA cites three incidents over the past five years where glucose results were overestimated, masking potential hypoglycemia...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT018287

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel